Financials

  • Market Capitalization 498.74 M
  • Employee 40
  • Founded 2022
  • CEO N/A
  • Website www.zurabio.com
  • Headquarter Cayman Islands
  • FIGI UNKNOWN
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.46
Rapporto prezzo/fatturato
-8 738.88

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2909
VSTM
Verastem, Inc. - Common Stock
5.77 USD+0.70%+6.85%+36.08%+11.61%507.03 M USD
2921
XOMA
XOMA Royalty Corporation - Common Stock
40.17 USD0.00%-8.39%-3.99%+13.96%503.77 M USD
2936
NVCT
Nuvectis Pharma, Inc. - Common Stock
18.60 USD-5.05%-1.38%+44.30%+131.63%493.37 M USD
2941
PROK
ProKidney Corp. - Class A Ordinary Shares
1.61 USD+0.62%-9.55%-8.52%-22.60%486.32 M USD

Notizie